BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 38731821)

  • 1. A Comparative Study of the Antiemetic Effects of α
    Sun Y; Darmani NA
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pivotal role of glycogen synthase kinase 3 (GSK-3) in vomiting evoked by specific emetogens in the least shrew (Cryptotis parva).
    Zhong W; Darmani NA
    Neurochem Int; 2020 Jan; 132():104603. PubMed ID: 31738972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for Bell-Shaped Dose-Response Emetic Effects of Temsirolimus and Analogs: The Broad-Spectrum Antiemetic Efficacy of a Large Dose of Temsirolimus Against Diverse Emetogens in the Least Shrew (
    Belkacemi L; Sun Y; Darmani NA
    Front Pharmacol; 2022; 13():848673. PubMed ID: 35444553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broad-spectrum antiemetic potential of the L-type calcium channel antagonist nifedipine and evidence for its additive antiemetic interaction with the 5-HT(3) receptor antagonist palonosetron in the least shrew (Cryptotis parva).
    Darmani NA; Zhong W; Chebolu S; Vaezi M; Alkam T
    Eur J Pharmacol; 2014 Jan; 722():2-12. PubMed ID: 24513517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broad-spectrum antiemetic efficacy of the L-type calcium channel blocker amlodipine in the least shrew (Cryptotis parva).
    Zhong W; Chebolu S; Darmani NA
    Pharmacol Biochem Behav; 2014 May; 120():124-32. PubMed ID: 24631485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultra-low doses of the transient receptor potential vanilloid 1 agonist, resiniferatoxin, prevents vomiting evoked by diverse emetogens in the least shrew (Cryptotis parva).
    Darmani NA; Henry DA; Zhong W; Chebolu S
    Behav Pharmacol; 2020 Feb; 31(1):3-14. PubMed ID: 31503071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Contribution of Phospholipase C in Vomiting in the Least Shrew (Cryptotis Parva) Model of Emesis.
    Zhong W; Darmani NA
    Front Pharmacol; 2021; 12():736842. PubMed ID: 34566660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of the least shrew as a rapid and selective screening model for the antiemetic potential and brain penetration of substance P and NK1 receptor antagonists.
    Darmani NA; Wang Y; Abad J; Ray AP; Thrush GR; Ramirez J
    Brain Res; 2008 Jun; 1214():58-72. PubMed ID: 18471804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic antiemetic interactions between serotonergic 5-HT3 and tachykininergic NK1-receptor antagonists in the least shrew (Cryptotis parva).
    Darmani NA; Chebolu S; Amos B; Alkam T
    Pharmacol Biochem Behav; 2011 Oct; 99(4):573-9. PubMed ID: 21683089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular emetic signaling evoked by the L-type Ca
    Zhong W; Chebolu S; Darmani NA
    Eur J Pharmacol; 2018 Sep; 834():157-168. PubMed ID: 29966616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids against radiation-induced emesis in the least shrew.
    Darmani NA; Janoyan JJ; Crim J; Ramirez J
    Eur J Pharmacol; 2007 Jun; 563(1-3):187-96. PubMed ID: 17362921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delta-9-tetrahydrocannabinol differentially suppresses emesis versus enhanced locomotor activity produced by chemically diverse dopamine D2/D3 receptor agonists in the least shrew (Cryptotis parva).
    Darmani NA; Crim JL
    Pharmacol Biochem Behav; 2005 Jan; 80(1):35-44. PubMed ID: 15652378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive antiemetic efficacy of low-doses of the cannabinoid CB(1/2) receptor agonist Δ(9)-THC with ultralow-doses of the vanilloid TRPV1 receptor agonist resiniferatoxin in the least shrew (Cryptotis parva).
    Darmani NA; Chebolu S; Zhong W; Trinh C; McClanahan B; Brar RS
    Eur J Pharmacol; 2014 Jan; 722():147-55. PubMed ID: 24157976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor-selective agonists induce emesis and Fos expression in the brain and enteric nervous system of the least shrew (Cryptotis parva).
    Ray AP; Chebolu S; Darmani NA
    Pharmacol Biochem Behav; 2009 Nov; 94(1):211-8. PubMed ID: 19699757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of D2 and D3 dopamine receptors in the mediation of emesis in Cryptotis parva (the least shrew).
    Darmani NA; Zhao W; Ahmad B
    J Neural Transm (Vienna); 1999; 106(11-12):1045-61. PubMed ID: 10651102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central and peripheral emetic loci contribute to vomiting evoked by the Akt inhibitor MK-2206 in the least shrew model of emesis.
    Zhong W; Chebolu S; Darmani NA
    Eur J Pharmacol; 2021 Jun; 900():174065. PubMed ID: 33775646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
    Darmani NA; Johnson JC
    Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal transduction pathways involved in dopamine D
    Belkacemi L; Zhong W; Darmani NA
    Auton Neurosci; 2021 Jul; 233():102807. PubMed ID: 33865060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HCN Channel Blocker ZD7288 Induces Emesis in the Least Shrew (
    Zhong W; Darmani NA
    Front Pharmacol; 2021; 12():647021. PubMed ID: 33995059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thapsigargin-induced activation of Ca(2+)-CaMKII-ERK in brainstem contributes to substance P release and induction of emesis in the least shrew.
    Zhong W; Chebolu S; Darmani NA
    Neuropharmacology; 2016 Apr; 103():195-210. PubMed ID: 26631534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.